Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Opus Genetics, Inc.
Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital
May 24, 2026
Opus Genetics Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
May 22, 2026
Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update
May 17, 2026
Opus Genetics to Present at Upcoming Investor Conferences in March 2026
May 16, 2026
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
February 2, 2026
Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
January 27, 2026
←
Previous Page
1
2